HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 09, September 2020 – 3D Technology: Additive Manufacturing Applications and Prospects       » Results of CD30 CAR-T Cell Therapy Trial Shows Promise for Hodgkin Lymphoma Patients       » Emerging Technologies and Innovations amid a Global Pandemic       » Monitoring COVID-19 Patients with AI-powered Platform       » Singapore Researchers Devise a Rapid COVID-19 Test Kit for the Detection of Neutralising Antibodies (NAbs) Against SARS-CoV-2       » Novel Ventilator Conceptualized by Singapore Clinicians Provides Efficient and Personalized Breathing Support for COVID-19 patients      
Vol 23, No. 11, November 2019   |   Issue PDF view/purchase
EYE ON CHINA
Researchers Try "One-Two Punch" Method to Treat Liver Cancer
An international team of researchers have found a "one-two punch" method to treat liver cancer by inducing weakness in liver cancer cells and exploiting the vulnerability to reduce tumour growth.

Researchers from Shanghai Jiao Tong University's School of Medicine and the Netherlands Cancer Institute found they can selectively induce senescence in liver cancer cells with mutations in a gene named TP53.

Senescence means the loss of a cell's power of division and growth, similar to putting the cell into a sleep mode.

The researchers said that the cells in the sleep mode have an "acquired vulnerability" and a follow-up screening will select a suitable chemical agent to target the vulnerability and kill cancer cells.

They said the two-step treatment is like the classic "one-two punch" from boxing. A combination of two blows is delivered in rapid succession: a left jab to expose the cancer cell's weak points quickly followed by a right cross to knock them out.

Meanwhile, the treatment has minimal side effects on other cells in normal proliferation, they added.

According to the research published in the journal Nature early this month, the treatment resulted in a marked reduction of tumor growth in mouse models of liver cancer.

The researchers said their study indicates that exploiting an induced vulnerability could be an effective treatment for liver cancer.

Liver cancer is a common malignant tumor with poor prognosis. Surgery and liver transplants so far are the most effective treatments. However, due to the difficulty of early diagnosis and rapid progression of the disease, most patients are unable to undergo surgery when they are diagnosed.

(Source: Xinhua)

NEWS CRUNCH  
news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy